Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Short term Debt (2016 - 2025)

HealthLynked (HLYK) has disclosed Short term Debt for 9 consecutive years, with $75732.0 as the latest value for Q3 2025.

  • On a quarterly basis, Short term Debt changed N/A to $75732.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $75732.0, a N/A change, with the full-year FY2022 number at $100068.0, down 75.2% from a year prior.
  • Short term Debt was $75732.0 for Q3 2025 at HealthLynked, up from $16285.0 in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $689083.0 in Q1 2021 to a low of $3209.0 in Q2 2023.
  • A 4-year average of $203018.9 and a median of $128074.0 in 2022 define the central range for Short term Debt.
  • Peak YoY movement for Short term Debt: crashed 42.52% in 2021, then plummeted 98.46% in 2023.
  • HealthLynked's Short term Debt stood at $403466.0 in 2021, then plummeted by 75.2% to $100068.0 in 2022, then tumbled by 96.79% to $3209.0 in 2023, then surged by 2259.99% to $75732.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Short term Debt are $75732.0 (Q3 2025), $16285.0 (Q2 2025), and $16979.0 (Q1 2025).